(IN BRIEF) Scientists at the Institute of Cancer Research in London have developed an innovative algorithm named SYLVER, which analyzes data from over 9,300 patients to identify synthetic lethal gene pairs that cancer cells depend on for survival. Unlike previous … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged 300 patients, 9, algorithm, backup genes, BRCA mutations, Breast Cancer Now, buffering mechanism, Cancer, Cancer Genome Atlas, Cancer Research UK, Dr Hattie Brooks, Dr Simon Vincent, Dr Syed Haider, inhibitor drugs, Institute of Cancer Research, London, NIHR Biomedical Research Centre, Professor Chris Lord, protein targets, Royal Marsden NHS Foundation Trust, SYLVER, synthetic lethality, targeted therapies, tumour-suppressor genes, Walk the Walk
(IN BRIEF) Researchers have made a significant breakthrough in cancer drug discovery by identifying a new binding site on the eukaryotic initiation factor 4E (eIF4E), a protein long considered undruggable. The collaborative study between The Institute of Cancer Research (ICR) … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged anticancer therapies, Astex Pharmaceuticals, breast cancer, Cancer Drug Discovery, Cancer Research UK, cancer treatment, Centre for Cancer Drug Discovery, drug development, druggable binding sites, eIF4E, eIF4G, fragment-based screening, ICR, Institute of Cancer Research, Nature Communications, new drug targets, Olivia Rossanese, Paul Clarke, prostate cancer, protein degradation, protein synthesis, protein synthesis regulation, small molecule inhibitors, therapeutic innovation, undruggable protein
(IN BRIEF) A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown promising results in diagnosing oral cancer. The device uses a … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer diagnosis, cancer prognosis, Cancer Research UK, clinical application, commercialization, early cancer detection, funding, haematoxylin and eosin staining, i4i programme, infrared spectral images, LDIR Wand, Liverpool Diagnostic Infrared Wand, Liverpool Head and Neck Cancer Centre, machine learning algorithm, National Institute for Health and Care Research, oral cancer, Professor Peter Weightman, Professor Richard Shaw, technological innovation, tissue analysis, University of Liverpool, “prototype”
SWINDON, 12-Apr-2018 — /EuropaWire/ — STFC and EPSRC have launched a joint funding call with Cancer Research UK that aims to drive forward earlier detection of cancer. The new funding called ‘Early Detection Innovation Sandpit and Award’ is available to researchers, … Read the full press release
Posted in Healthcare, Science, Technology, United Kingdom
Tagged biopsy, Cancer, Cancer Research UK, earlier detection of cancer, EPSRC, funding, STFC
LEEDS, 16-Feb-2017 — /EuropaWire/ — GPs want more support when offering drugs that lower the risk of certain cancers, a new report by the University of Leeds and Cancer Research UK reveals. The report explores how much GPs know about … Read the full press release
SOUTHAMPTON, 29-Nov-2016 — /EuropaWire/ — Researchers at the University of Southampton have engineered cells with a ‘built-in genetic circuit’ that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment. The genetic circuit … Read the full press release
DUNDEE, 07-Oct-2016 — /EuropaWire/ — A talented international scientist has been awarded £1.35million from Cancer Research UK to bring her ground breaking research into how tumours develop to the University of Dundee. Dr Constance Alabert is one of only three researchers … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged cancer research, Cancer Research UK, Dr Constance Alabert, Karen Noble, University of Dundee
The University of Aberdeen has secured a grant of up to £1.5million from Cancer Research UK to study how tumours develop. ABERDEEN, 18-3-2015 — /EuropaWire/ — The grant will fund a five-year programme of research led by Professor Anne Donaldson … Read the full press release
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs. BRIGHTON, 2-3-2015 — /EuropaWire/ — A major computational analysis by scientists at the University of Sussex and The Institute of Cancer Research, … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged Cancer Research UK, Daphne Jackson Trust, Dr Bissan Al-Lazikani, Dr Frances Pearl, drugs that exploit the inherent weaknesses of cancer cells, Nature Reviews Cancer, Professor Laurence Pearl, Professor Paul Workman, The Institute of Cancer Research, The Institute of Cancer Research scientists, Tony Carr, University of Sussex
SOUTHAMPTON, 16-12-2014 — /EuropaWire/ — Scientists at the University of Southampton have found that the precise shape of an antibody makes a big difference to how it can stimulate the body’s immune system to fight cancer, paving the way for much … Read the full press release
16-7-2013 — /europawire.eu/ — AstraZeneca today announced that it has entered into an agreement with the University of Cambridge and Cancer Research UK for a two-year collaboration on three pre-clinical and clinical oncology projects. This agreement with world-leading medical research institutions … Read the full press release
Posted in Business, Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, Babraham Institute, Cambridge University Hospitals, Cancer, cancer research, Cancer Research UK, cancers, collaboration, David Neal, medical research, Olaparib, oncology, oncology projects, pancreatic, prostate, selumetinib, Susan Galbraith, tumour mutations, University of Cambridge
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?